Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery

Christian Hoffmann(Hochschule für Angewandte Wissenschaften Kiel), Thorsten Rosenkranz(Asklepios Klinik St. Georg), Susanne Tabrizian(Asklepios Klinik St. Georg), Thomas Buhk(Universität Hamburg), Christian Eggers(Johannes Kepler University of Linz), Eva Wolf(MUC Research (Germany)), Hans Jäger, Albrecht Stoehr, Andreas Plettenberg(Institute for Interdisciplinary Medicine), Hans‐Jürgen Stellbrink, Heinz‐August Horst(Goethe University Frankfurt)
AIDS
November 1, 2001
10.1097/00002030-200111090-00007
Cited by 147

Related Papers

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
|The Lancet|2019|1k
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
|Blood|2005|537
International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease
|Blood|2018|421
HIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatment
|Journal of Neurology|2017|336